Prolonged carriage of resistant E. coli by returned travellers: Clonality, risk factors and bacterial characteristics

European Journal of Clinical Microbiology and Infectious Diseases

Volumn 31, Issue 9, 2012, Pages 2413-2420

  Rogers, B A ^a   Sidjabat, H E ^a   Paterson, D L ^a   Kennedy, K ^b   Collignon, P ^b   Jones, M ^c  

^a UNIVERSITY OF QUEENSLAND   (Australia)

^b CANBERRA HOSPITAL   (Australia)

^c UNIVERSITY OF QUEENSLAND   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN; AMOXICILLIN PLUS CLAVULANIC ACID; CEFAZOLIN; CEFTRIAXONE; CIPROFLOXACIN; COTRIMOXAZOLE; GENTAMICIN; NALIDIXIC ACID;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL GENE; BACTERIAL STRAIN; BACTERIAL TRANSMISSION; BACTERIUM CARRIER; BACTERIUM CULTURE; BACTERIUM ISOLATION; CLONAL VARIATION; COHORT ANALYSIS; CONTROLLED STUDY; DRUG USE; DYNAMICS; ESCHERICHIA COLI; HORIZONTAL GENE TRANSFER; HOST PATHOGEN INTERACTION; HUMAN; MULTIDRUG RESISTANCE; NONHUMAN; NUCLEIC ACID ANALYSIS; PHENOTYPE; PHYLOGENY; PLASMID; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RECTUM SMEAR; REPETITIVE EXTRAGENIC PALINDROMIC POLYMERASE CHAIN REACTION; RISK FACTOR; SMEAR; TRAVEL;

ANTI-BACTERIAL AGENTS; CARRIER STATE; CLUSTER ANALYSIS; DNA, BACTERIAL; DRUG RESISTANCE, BACTERIAL; ESCHERICHIA COLI; ESCHERICHIA COLI INFECTIONS; FEMALE; GENOTYPE; HUMANS; LONGITUDINAL STUDIES; MALE; MOLECULAR TYPING; RISK FACTORS; TIME FACTORS; TRAVEL; TRAVEL MEDICINE;

EID: 84866419395     PISSN: 09349723     EISSN: 14354373     Source Type: Journal    
DOI: 10.1007/s10096-012-1584-z     Document Type: Article

References (24)

1. Tham J, Odenholt I, Walder M, Brolund A, Ahl J, Melander E (2010) Extended-spectrum beta-lactamase-producing Escherichia coli in patients with travellers' diarrhoea. Scand J Infect Dis 42 (4):275-280
2. Tangden T, Cars O, Melhus A, Lowdin E (2010) Foreign travel is a major risk factor for colonization with Escherichia coli producing CTX-M-type extended-spectrum beta-lactamases: a prospective study with Swedish volunteers. Antimicrob Agents Chemother 54(9):3564-3568
3. Dhanji H, Patel R, Wall R, Doumith M, Patel B, Hope R, Livermore DM, Woodford N (2011) Variation in the genetic environments of bla(CTX-M-15) in Escherichia coli from the faeces of travellers returning to the United Kingdom. J Antimicrob Chemother 66(5):1005-1012
4. Kennedy K, Collignon P (2010) Colonisation with Escherichia coli resistant to "critically important" antibiotics: a high risk for international travellers. Eur J Clin Microbiol Infect Dis 29 (12):1501-1506
5. Peirano G, Laupland KB, Gregson DB, Pitout JD (2011) Colonization of returning travelers with CTX-M-producing Escherichia coli. J Travel Med 18(5):299-303
6. O'Fallon E, Gautam S, D'Agata EM (2009) Colonization with multidrug-resistant gram-negative bacteria: prolonged duration and frequent cocolonization. Clin Infect Dis 48(10):1375-1381
7. Lautenbach E, Tolomeo P, Mao X, Fishman NO, Metlay JP, Bilker WB, Nachamkin I (2006) Duration of outpatient fecal colonization due to Escherichia coli isolates with decreased susceptibility to fluoroquinolones: longitudinal study of patients recently discharged from the hospital. Antimicrob Agents Chemother 50 (11):3939-3943
8. Horcajada JP, Vila J, Moreno-Martinez A, Ruiz J, Martinez JA, Sanchez M, Soriano E, Mensa J (2002) Molecular epidemiology and evolution of resistance to quinolones in Escherichia coli after prolonged administration of ciprofloxacin in patients with prostatitis. J Antimicrob Chemother 49(1):55-59
9. Weintrob AC, Roediger MP, Barber M, Summers A, Fieberg AM, Dunn J, Seldon V, Leach F, Huang XZ, Nikolich MP, Wortmann GW (2010) Natural history of colonization with gram-negative multidrug-resistant organisms among hospitalized patients. Infect Control Hosp Epidemiol 31(4):330-337
10. Oethinger M, Jellen-Ritter AS, Conrad S, Marre R, Kern WV (1998) Colonization and infection with fluoroquinolone-resistant Escherichia coli among cancer patients: clonal analysis. Infection 26(6):379-384
11. Stuart RL, Kotsanas D, Webb B, Vandergraaf S, Gillespie EE, Hogg GG, Korman TM (2011) Prevalence of antimicrobialresistant organisms in residential aged care facilities. Med J Aust 195(9):530-533
12. Sidjabat HE, Silveira FP, Potoski BA, Abu-Elmagd KM, Adams-Haduch JM, Paterson DL, Doi Y (2009) Interspecies spread of Klebsiella pneumoniae carbapenemase gene in a single patient. Clin Infect Dis 49(11):1736-1738
13. Kennedy KJ, Roberts JL, Collignon PJ (2008) Escherichia coli bacteraemia in Canberra: incidence and clinical features. Med J Aust 188(4):209-213
14. Clermont O, Bonacorsi S, Bingen E (2000) Rapid and simple determination of the Escherichia coli phylogenetic group. Appl Environ Microbiol 66(10):4555-4558
15. Clermont O, Dhanji H, Upton M, Gibreel T, Fox A, Boyd D, Mulvey MR, Nordmann P, Ruppe E, Sarthou JL, Frank T, Vimont S, Arlet G, Branger C, Woodford N, Denamur E (2009) Rapid detection of the O25b-ST131 clone of Escherichia coli encompassing the CTX-M-15-producing strains. J Antimicrob Chemother 64(2):274-277
16. Rodriguez-Bano J, Navarro MD, Romero L, Martinez-Martinez L, Muniain MA, Perea EJ, Perez-Cano R, Pascual A (2004) Epidemiology and clinical features of infections caused by extendedspectrum beta-lactamase-producing Escherichia coli in nonhospitalized patients. J Clin Microbiol 42(3):1089-1094
17. Patel U, Dasgupta P, Amoroso P, Challacombe B, Pilcher J, Kirby R (2011) Infection after transrectal ultrasonography-guided prostate biopsy: increased relative risks after recent international travel or antibiotic use. BJU Int doi:10.1111/j.1464-410X.2011.10561.x
18. Laupland KB, Church DL, Vidakovich J, Mucenski M, Pitout JD (2008) Community-onset extended-spectrum beta-lactamase (ESBL) producing Escherichia coli: importance of international travel. J Infect 57(6):441-448
19. Gupta K, Hooton TM, Naber KG, Wullt B, Colgan R, Miller LG, Moran GJ, Nicolle LE, Raz R, Schaeffer AJ, Soper DE (2011) International clinical practice guidelines for the treatment of acute uncomplicated cystitis and pyelonephritis in women: a 2010 update by the Infectious Diseases Society of America and the European Society for Microbiology and Infectious Diseases. Clin Infect Dis 52(5):e103-e120
20. Antibiotic Expert Group, Spicer J, Therapeutic Guidelines Limited (2010) Therapeutic guidelines: antibiotic. Therapeutic Guidelines, Melbourne, p xxxiv, 445
21. Willing BP, Russell SL, Finlay BB (2011) Shifting the balance: antibiotic effects on host-microbiota mutualism. Nat Rev Microbiol 9(4):233-243
22. Manges AR, Tabor H, Tellis P, Vincent C, Tellier PP (2008) Endemic and epidemic lineages of Escherichia coli that cause urinary tract infections. Emerg Infect Dis 14(10):1575-1583
23. Rogers BA, Aminzadeh Z, Hayashi Y, Paterson DL (2011) Country-to-country transfer of patients and the risk of multiresistant bacterial infection. Clin Infect Dis 53(1):49-56
24. Bailey JK, Pinyon JL, Anantham S, Hall RM (2010) Distribution of human commensal Escherichia coli phylogenetic groups. J Clin Microbiol 48(9):3455-3456